Group 1 - InMode Ltd. (NASDAQ: INMD) is highlighted as a company with strong fundamentals trading at lower market multiples, which is rare in the current market environment [1] - The company has consistently posted impressive financials since its inception, indicating robust operational performance [1] - The author emphasizes a value investing approach, focusing on deep value plays and conservative discounted cash flow calculations, which aligns with the investment philosophy of renowned investors like Warren Buffett and Benjamin Graham [1]

Core Viewpoint - InMode Ltd. has rescheduled its fourth quarter and full year 2024 earnings conference call to February 4, 2025, at 8:30 a.m. Eastern Standard Time, with financial results to be released before the market opens on the same day [1][2]. Group 1: Conference Call Details - The conference call will feature presentations from key management, including the CEO, CFO, and CTO [2]. - Participants are encouraged to pre-register for the conference call to receive a unique dial-in number for immediate access [3]. - For those who do not pre-register, alternative dial-in numbers are provided, along with a webcast link for live streaming [4]. Group 2: Company Overview - InMode is recognized as a leading global provider of innovative medical technologies, focusing on devices that utilize novel radiofrequency technology [5]. - The company aims to enhance surgical procedures and improve existing treatments through its minimally invasive RF technologies, offering a diverse range of products across various medical fields [5].

Article Summary - The article discusses the recent performance of InMode, a company whose stock has been underperforming, as indicated by the author's search for images on Seeking Alpha, which returned unrelated results [1] Author's Background and Methodology - The author has been investing since 2013 and uses quantitative methods to identify undervalued stocks across various industries [1] - The author emphasizes the importance of numbers over narratives in evaluating a company's prospects [1] - The author has a background in reading numerous stock market books, including "100 Baggers," "Financial Shenanigans," and "The Quants" [1] Disclosure - The author holds a long position in InMode through stock ownership, options, or other derivatives [2] - The article reflects the author's personal opinions and is not influenced by compensation or business relationships with the mentioned companies [2]

Conference call to be held on Thursday, February 6, 2025, at 8:30 a.m. Eastern Standard Time YOKNEAM, Israel, Jan. 8, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the fourth quarter and full year 2024 before the Nasdaq market opens on Thursday, February 6, 2025. InMode is currently finalizing its financial results for the fourth quarter and full year of 2024. Management beli ...

Company Performance - InMode Ltd reports impressive net income growth driven by the sale of non-invasive surgical products [1] - The company recently launched two new platforms, Define and Envision, which are expected to contribute to future business growth [1] Analyst Background - The analyst has nearly 14 years of experience in the financial industry, having worked for an equity research firm in NY, an investment fund in Mexico, and an investment bank in Ireland [1] - The analyst currently focuses on mature industries such as mining, oil and gas, and real estate, and targets investments with an internal rate of return of 5%-7% [1] - The analyst does not invest in business models they do not understand and appreciates M&A deals, deep value investments, and dividend investing [1] Disclosure - The analyst holds a beneficial long position in InMode Ltd through stock ownership, options, or other derivatives [2] - The article expresses the analyst's own opinions and they are not receiving compensation for it other than from Seeking Alpha [2] - The analyst has no business relationship with any company mentioned in the article [2]

InMode (NASDAQ: INMD ) recently reported its Q3-2024 results, so it's time to revisit the stock. I last wrote about InMode on September 6 and called it an " inverse bubble caused by short-term I objectively search for undervalued stocks of any size across a wide variety of industries using quantitative methods that I've thoroughly backtested for success. I believe the numbers are more important than the story (most of the time), as they tend to paint a more realistic picture of the company's prospects. I ha ...

InMode’s (NASDAQ: INMD ) products are part of the medical aesthetics industry that is expected to grow at an 11% CAGR over the next five years. Despite a punishing macro environment of late that hasI have been investing in the stock market since I was 17 years old, and over the 25+ years since I have learned the joy of compounding, the value of dividend reinvesting, and the principle that patient investing through good times and bad brings the greatest rewards. I believe the key to creating wealth is the sl ...

InMode Ltd. (NASDAQ:INMD) Q3 2024 Earnings Conference Call October 30, 2024 8:30 AM ET Company Participants Miri Segal - CEO, MS-IR Moshe Mizrahy - Chief Executive Officer Michael Kreindel - Chief Technology Officer Yair Malca - Chief Financial Officer Eran Krieger - Medical Director and VP of Medical Affairs Rafael Lickerman - Vice President, Finance Conference Call Participants Matt Miksic - Barclays Caitlin Cronin - Canaccord Genuity Sam Eiber - BTIG Operator Good day, and welcome to the InMode's Third Q ...

InMode (INMD) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.61 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 22.81%. A quarter ago, it was expected that this maker of cosmetic surgery devices would post earnings of $0.30 per share when it actually produced earnings of $0.34, delivering a surprise of 13.33%. Over the last four quar ...

YOKNEAM, Israel, Oct. 30, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights: Quarterly GAAP revenue of $130.2 million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024). Quarterly revenues from consumables and service of $15.8 million, a decrease of ...